A letter of intent was signed to align EQ Labs, Inc. (EQLB) and KANGE CORP. (KGNR)
Las Vegas, NV -- August 23, 2021 -- InvestorsHub
NewsWire
A letter of intent was
signed to align EQ Labs, Inc. (EQLB)
and KANGE CORP. (KGNR) To explore the possibility of an
acquisition that will strengthen the position and placement of Last
Shot® in the marketplace. “We’ve looked at all of our options that
could possibly benefit the Last Shot ® brand. We also
considered what would bring value to shareholders, and support our
business model. We are excited that our new potential
alignment with KANGE CORP. (KGNR) will meet and exceed all of our
expectations” said Mo Owens, EQ Labs Inc. CEO and Founder. Please
look for additional announcements in the coming weeks as
developments continue.
August 23, 2021, EQ Labs has
entered an LOI with another public company to explore the
possibility of an acquisition of EQ LABS INC. We as a company feel
that we should explore all viable options going forward that is in
the best interest of our shareholders especially as the company is
closer than ever to executing our business model. We will keep our
shareholders informed.

Safe
Harbor:
This
news release contains forward-looking statements as that term is
defined in Section 27A of the United States Securities Act of 1933,
as amended and Section 21E of the Securities Exchange Act of 1934,
as amended. Statements in this press release, which are not purely
historical, are forward-looking statements and include any
statements regarding beliefs, plans, expectations or intentions
regarding the future. These forward-looking statements generally
can be identified by phrases such as EQ Labs, Inc. or its
management believes, expects, anticipates, foresees, forecasts,
estimates or other words or phrases of similar import. Such
forward-looking statements include, among other things, the
development, costs and results of new business opportunities.
Actual results could differ from those projected in any
forward-looking statements due to numerous factors. Such factors
include, among others, the inherent uncertainties associated with
new business opportunities and development stage companies. These
forward-looking statements are made as of the date of this news
release, and we assume no obligation to update the forward-looking
statements, or to update the reasons why actual results could
differ from those projected in the forward-looking statements.
Although we believe that any beliefs, plans, expectations and
intentions contained in this press release are reasonable, there
can be no assurance that any such beliefs, plans, expectations or
intentions will prove to be accurate. Investors should consult all
the information set forth herein and should also refer to the risk
factors disclosure outlined in our annual report, our quarterly
reports and other periodic reports filed from time-to-time with the
OTC Markets.
Contact
Information:
3032 so Polaris’s
suite #20
Las
Vegas NV. 89118
Cell: (702) 806-5943
Mo@drinklastshotlv.com
WWW.lastshotofficial.com
EQ Labs (PK) (USOTC:EQLB)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
EQ Labs (PK) (USOTC:EQLB)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
EQ Labs Inc (PK) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More EQ Labs Inc (PK) News Articles